Angle Plc (ANPCF) 1.5400 $ANPCF
US Prenatal Testing Market 2014-2018: PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Dominate the Industry
M2 - Wed Apr 30, 5:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7lqfr2/prenatal_testing) has announced the addition of the "US Prenatal Testing Market 2014-2018: PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Dominate the Industry" report to their offering. The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aum?ne, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate, and fragile X syndrome. Further, the report states that one of the major challenges is the decline in fertility rates all over the world. The decline in the fertility rate will lead to a decline in pregnancies, which in turn will lead to a reduction in the demand for prenatal testing during the forecast period. Key vendors dominating this space are: - PerkinElmer Inc - Quest Diagnostics Inc. - Sequenom Inc. - Verinata Health Inc. Other vendors mentioned in the report are: - ANGLE plc - Ariosa Diagnostics Inc - BGI Health - CellScape Corp - Fluidigm Corp. - Ikonisys Inc - Kellbenx Inc - Natera Inc - Ravgen Inc. - Trovagene Inc. For more information visit http://www.researchandmarkets.com/research/7l...al_testing
US Prenatal Testing Market 2014-2018: PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Dominate the Industry
M2 - Wed Apr 30, 5:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7lqfr2/prenatal_testing) has announced the addition of the "US Prenatal Testing Market 2014-2018: PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Dominate the Industry" report to their offering. The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aum?ne, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate, and fragile X syndrome. Further, the report states that one of the major challenges is the decline in fertility rates all over the world. The decline in the fertility rate will lead to a decline in pregnancies, which in turn will lead to a reduction in the demand for prenatal testing during the forecast period. Key vendors dominating this space are: - PerkinElmer Inc - Quest Diagnostics Inc. - Sequenom Inc. - Verinata Health Inc. Other vendors mentioned in the report are: - ANGLE plc - Ariosa Diagnostics Inc - BGI Health - CellScape Corp - Fluidigm Corp. - Ikonisys Inc - Kellbenx Inc - Natera Inc - Ravgen Inc. - Trovagene Inc. For more information visit http://www.researchandmarkets.com/research/7l...al_testing
